{"id":35811,"date":"2023-03-29T10:44:16","date_gmt":"2023-03-29T08:44:16","guid":{"rendered":"https:\/\/www.satt.fr\/french-tech-health20-7-startups-satt-au-sein-de-la-premiere-promotion\/"},"modified":"2023-03-29T10:45:51","modified_gmt":"2023-03-29T08:45:51","slug":"french-tech-health20","status":"publish","type":"post","link":"https:\/\/www.satt.fr\/en\/french-tech-health20\/","title":{"rendered":"French Tech Health20 : 7 startups SATT au sein de la premi\u00e8re promotion !"},"content":{"rendered":"<div id=\"pl-35811\"  class=\"panel-layout\" ><div id=\"pg-35811-0\"  class=\"panel-grid panel-no-style\" ><div id=\"pgc-35811-0-0\"  class=\"panel-grid-cell\" ><div id=\"panel-35811-0-0-0\" class=\"so-panel widget widget_sow-editor panel-first-child panel-last-child\" data-index=\"0\" ><div\n\t\t\t\n\t\t\tclass=\"so-widget-sow-editor so-widget-sow-editor-base\"\n\t\t\t\n\t\t>\n<div class=\"siteorigin-widget-tinymce textwidget\">\n\t<p><strong>Le 28 mars, Jean-No\u00ebl Barrot, Ministre d\u00e9l\u00e9gu\u00e9 charg\u00e9 de la Transition num\u00e9rique et des T\u00e9l\u00e9communications, Clara Chappaz, Directrice de la Mission French Tech et Lise Alter, Directrice g\u00e9n\u00e9rale de l\u2019Agence de l\u2019innovation en sant\u00e9 (SGPI), ont d\u00e9voil\u00e9s les laur\u00e9ats du programme French Tech Health20. 21 startups ont \u00e9t\u00e9 s\u00e9lectionn\u00e9es pour participer au programme d\u2019acc\u00e9l\u00e9ration, dont 7 accompagn\u00e9es par des SATT.<\/strong><\/p>\n<\/div>\n<\/div><\/div><\/div><\/div><div id=\"pg-35811-1\"  class=\"panel-grid panel-no-style\" ><div id=\"pgc-35811-1-0\"  class=\"panel-grid-cell\" ><div id=\"panel-35811-1-0-0\" class=\"so-panel widget widget_sow-editor panel-first-child panel-last-child\" data-index=\"1\" ><div\n\t\t\t\n\t\t\tclass=\"so-widget-sow-editor so-widget-sow-editor-base\"\n\t\t\t\n\t\t>\n<div class=\"siteorigin-widget-tinymce textwidget\">\n\t<h2 style=\"text-align: center;\"><strong>French Tech Health20<\/strong><\/h2>\n<\/div>\n<\/div><\/div><\/div><\/div><div id=\"pg-35811-2\"  class=\"panel-grid panel-no-style\" ><div id=\"pgc-35811-2-0\"  class=\"panel-grid-cell\" ><div id=\"panel-35811-2-0-0\" class=\"so-panel widget widget_sow-editor panel-first-child panel-last-child\" data-index=\"2\" ><div\n\t\t\t\n\t\t\tclass=\"so-widget-sow-editor so-widget-sow-editor-base\"\n\t\t\t\n\t\t>\n<div class=\"siteorigin-widget-tinymce textwidget\">\n\t<p>Le programme French Tech Health20 vise \u00e0 accompagner les startups qui souhaitent innover au service de la souverainet\u00e9 technologique, industrielle et sanitaire de la France.<\/p>\n<p>Apr\u00e8s le Green20, Agri20 et DeepNum20, il s\u2019agit du quatri\u00e8me programme lanc\u00e9 par la Mission French Tech dans le cadre de sa strat\u00e9gie d\u2019accompagnement des jeunes pousses (start-ups) proposant des innovations de rupture sur les grands enjeux de soci\u00e9t\u00e9. Retrouvez les <a href=\"https:\/\/www.satt.fr\/frenchtech-deepnum20\/\">laur\u00e9ats SATT<\/a> des programmes Green20, Agri20 et DeepNum20.<\/p>\n<p>La premi\u00e8re \u00e9dition du programme French Tech Health20 a \u00e9t\u00e9 construite afin d\u2019accompagner des start-up qui d\u00e9veloppent des innovations de rupture particuli\u00e8rement prometteuses, dans les domaines prioritaires \u201dInnovation Sante\u0301 2030\u201d, en lien \u00e9troit avec l\u2019Agence de l\u2019innovation en sante\u0301.<\/p>\n<\/div>\n<\/div><\/div><\/div><div id=\"pgc-35811-2-1\"  class=\"panel-grid-cell\" ><div id=\"panel-35811-2-1-0\" class=\"so-panel widget widget_media_image panel-first-child panel-last-child\" data-index=\"3\" ><img loading=\"lazy\" decoding=\"async\" width=\"244\" height=\"244\" src=\"https:\/\/www.satt.fr\/wp-content\/uploads\/2023\/03\/FT-Logo-Health20-300x300-1.png\" class=\"image wp-image-35729  attachment-full size-full\" alt=\"\" style=\"max-width: 100%; height: auto;\" srcset=\"https:\/\/www.satt.fr\/wp-content\/uploads\/2023\/03\/FT-Logo-Health20-300x300-1.png 244w, https:\/\/www.satt.fr\/wp-content\/uploads\/2023\/03\/FT-Logo-Health20-300x300-1-150x150.png 150w, https:\/\/www.satt.fr\/wp-content\/uploads\/2023\/03\/FT-Logo-Health20-300x300-1-100x100.png 100w\" sizes=\"auto, (max-width: 244px) 100vw, 244px\" \/><\/div><\/div><\/div><div id=\"pg-35811-3\"  class=\"panel-grid panel-no-style\" ><div id=\"pgc-35811-3-0\"  class=\"panel-grid-cell\" ><div id=\"panel-35811-3-0-0\" class=\"so-panel widget widget_sow-editor panel-first-child panel-last-child\" data-index=\"4\" ><div\n\t\t\t\n\t\t\tclass=\"so-widget-sow-editor so-widget-sow-editor-base\"\n\t\t\t\n\t\t>\n<div class=\"siteorigin-widget-tinymce textwidget\">\n\t<h2 style=\"text-align: center;\">Les laur\u00e9ats du programme<\/h2>\n<\/div>\n<\/div><\/div><\/div><\/div><div id=\"pg-35811-4\"  class=\"panel-grid panel-no-style\" ><div id=\"pgc-35811-4-0\"  class=\"panel-grid-cell\" ><div id=\"panel-35811-4-0-0\" class=\"so-panel widget widget_sow-editor panel-first-child panel-last-child\" data-index=\"5\" ><div\n\t\t\t\n\t\t\tclass=\"so-widget-sow-editor so-widget-sow-editor-base\"\n\t\t\t\n\t\t>\n<div class=\"siteorigin-widget-tinymce textwidget\">\n\t<p>21 startups ont \u00e9t\u00e9 s\u00e9lectionn\u00e9es dans 7 r\u00e9gions diff\u00e9rentes pour participer au programme d\u2019acc\u00e9l\u00e9ration. Une s\u00e9lection fond\u00e9e sur des crit\u00e8res de potentiel \u00e9conomique et technologique. Ces start-ups technologiques d\u00e9veloppant des innovations de rupture en sant\u00e9 auront un an pour profiter du r\u00e9seau et de la visibilit\u00e9 de la Mission French Tech.<\/p>\n<p>La capacit\u00e9 des entreprises \u00e0 r\u00e9pondre aux grands enjeux de souverainet\u00e9 sanitaire, industrielle et technologique a \u00e9t\u00e9 analys\u00e9e au regard de leur aptitude \u00e0 d\u00e9velopper de nouvelles activit\u00e9s, qui peuvent devenir des domaines d\u2019excellence futurs. Par ailleurs, les solutions qu\u2019elles d\u00e9veloppent sont \u00e9galement susceptibles de contribuer significativement \u00e0 l\u2019objectif du Gouvernement de faire \u00e9merger 100 nouveaux sites industriels par an d\u2019ici 2025 puisqu\u2019une proportion importante est \u00e0 vocation industrielle.<\/p>\n<\/div>\n<\/div><\/div><\/div><div id=\"pgc-35811-4-1\"  class=\"panel-grid-cell\" ><div id=\"panel-35811-4-1-0\" class=\"so-panel widget widget_media_image panel-first-child panel-last-child\" data-index=\"6\" ><img loading=\"lazy\" decoding=\"async\" width=\"300\" height=\"300\" src=\"https:\/\/www.satt.fr\/wp-content\/uploads\/2023\/03\/Carrousel_FT_Health20-2_4-1024x1024-1-300x300.jpg\" class=\"image wp-image-35749  attachment-medium size-medium\" alt=\"\" style=\"max-width: 100%; height: auto;\" srcset=\"https:\/\/www.satt.fr\/wp-content\/uploads\/2023\/03\/Carrousel_FT_Health20-2_4-1024x1024-1-300x300.jpg 300w, https:\/\/www.satt.fr\/wp-content\/uploads\/2023\/03\/Carrousel_FT_Health20-2_4-1024x1024-1.jpg 1024w, https:\/\/www.satt.fr\/wp-content\/uploads\/2023\/03\/Carrousel_FT_Health20-2_4-1024x1024-1-150x150.jpg 150w, https:\/\/www.satt.fr\/wp-content\/uploads\/2023\/03\/Carrousel_FT_Health20-2_4-1024x1024-1-768x768.jpg 768w, https:\/\/www.satt.fr\/wp-content\/uploads\/2023\/03\/Carrousel_FT_Health20-2_4-1024x1024-1-500x500.jpg 500w, https:\/\/www.satt.fr\/wp-content\/uploads\/2023\/03\/Carrousel_FT_Health20-2_4-1024x1024-1-600x600.jpg 600w, https:\/\/www.satt.fr\/wp-content\/uploads\/2023\/03\/Carrousel_FT_Health20-2_4-1024x1024-1-100x100.jpg 100w\" sizes=\"auto, (max-width: 300px) 100vw, 300px\" \/><\/div><\/div><\/div><div id=\"pg-35811-5\"  class=\"panel-grid panel-no-style\" ><div id=\"pgc-35811-5-0\"  class=\"panel-grid-cell\" ><div id=\"panel-35811-5-0-0\" class=\"so-panel widget widget_sow-editor panel-first-child panel-last-child\" data-index=\"7\" ><div\n\t\t\t\n\t\t\tclass=\"so-widget-sow-editor so-widget-sow-editor-base\"\n\t\t\t\n\t\t>\n<div class=\"siteorigin-widget-tinymce textwidget\">\n\t<p><strong>Les 21 start-up s\u00e9lectionn\u00e9es pour int\u00e9grer le programme French Tech Health20 repr\u00e9sentent :<\/strong><\/p>\n<ul>\n<li>Des solutions au c\u0153ur des principaux enjeux de souverainet\u00e9 sanitaires, technologiques et industriels en particulier : sant\u00e9 num\u00e9rique (7), bioth\u00e9rapies et bioproduction (4), dispositifs m\u00e9dicaux innovants (6), maladies infectieuses \u00e9mergentes (4)<\/li>\n<li>7 r\u00e9gion repr\u00e9sent\u00e9es : \u00cele-de-France (12), Nouvelle-Aquitaine (3), Auvergne-Rh\u00f4ne-Alpes (2), Bourgogne-Franche-Comt\u00e9 (1), Grand Est (1), Haut-de-France (1), Pays de Loire (1)<\/li>\n<li>30% de femmes parmi les CEO et co-fondatrices.<\/li>\n<\/ul>\n<\/div>\n<\/div><\/div><\/div><\/div><div id=\"pg-35811-6\"  class=\"panel-grid panel-no-style\" ><div id=\"pgc-35811-6-0\"  class=\"panel-grid-cell\" ><div id=\"panel-35811-6-0-0\" class=\"so-panel widget widget_sow-editor panel-first-child panel-last-child\" data-index=\"8\" ><div\n\t\t\t\n\t\t\tclass=\"so-widget-sow-editor so-widget-sow-editor-base\"\n\t\t\t\n\t\t>\n<div class=\"siteorigin-widget-tinymce textwidget\">\n\t<h2 style=\"text-align: center;\"><strong>Les 7 laur\u00e9ats SATT<\/strong><\/h2>\n<\/div>\n<\/div><\/div><\/div><\/div><div id=\"pg-35811-7\"  class=\"panel-grid panel-no-style\" ><div id=\"pgc-35811-7-0\"  class=\"panel-grid-cell\" ><div id=\"panel-35811-7-0-0\" class=\"so-panel widget widget_sow-editor panel-first-child panel-last-child\" data-index=\"9\" ><div\n\t\t\t\n\t\t\tclass=\"so-widget-sow-editor so-widget-sow-editor-base\"\n\t\t\t\n\t\t>\n<div class=\"siteorigin-widget-tinymce textwidget\">\n\t<p><strong>EpiLAB<\/strong> (SAYENS) - <a href=\"https:\/\/www.epilab.io\/\">epilab.io<\/a><\/p>\n<p>EpiLAB est une entreprise qui vend un test portable de diagnostic de la tuberculose. Elle aide les organismes de sant\u00e9 \u00e0 lutter contre la tuberculose en comblant les lacunes en mati\u00e8re de diagnostic et en r\u00e9duisant la contamination. Le test s'appuie sur une technologie microbiologique de pointe brevet\u00e9e qui garantit des tests tr\u00e8s sensibles tout en \u00e9tant abordable pour les pays en d\u00e9veloppement, qui repr\u00e9sentent 80 % des cas de tuberculose. EpiLAB est bas\u00e9e \u00e0 l'Ecole Polytechnique, une grande \u00e9cole d'ing\u00e9nieurs en France, et recherche des investissements et des partenaires pour finaliser son kit de diagnostic et p\u00e9n\u00e9trer ses march\u00e9s.<\/p>\n<\/div>\n<\/div><\/div><\/div><div id=\"pgc-35811-7-1\"  class=\"panel-grid-cell\" ><div id=\"panel-35811-7-1-0\" class=\"so-panel widget widget_media_image panel-first-child panel-last-child\" data-index=\"10\" ><img loading=\"lazy\" decoding=\"async\" width=\"300\" height=\"158\" src=\"https:\/\/www.satt.fr\/wp-content\/uploads\/2023\/03\/LogoEPILAB-300x158.png\" class=\"image wp-image-35785  attachment-medium size-medium\" alt=\"\" style=\"max-width: 100%; height: auto;\" srcset=\"https:\/\/www.satt.fr\/wp-content\/uploads\/2023\/03\/LogoEPILAB-300x158.png 300w, https:\/\/www.satt.fr\/wp-content\/uploads\/2023\/03\/LogoEPILAB-1024x538.png 1024w, https:\/\/www.satt.fr\/wp-content\/uploads\/2023\/03\/LogoEPILAB-150x79.png 150w, https:\/\/www.satt.fr\/wp-content\/uploads\/2023\/03\/LogoEPILAB-768x403.png 768w, https:\/\/www.satt.fr\/wp-content\/uploads\/2023\/03\/LogoEPILAB-500x263.png 500w, https:\/\/www.satt.fr\/wp-content\/uploads\/2023\/03\/LogoEPILAB-600x315.png 600w, https:\/\/www.satt.fr\/wp-content\/uploads\/2023\/03\/LogoEPILAB-190x100.png 190w, https:\/\/www.satt.fr\/wp-content\/uploads\/2023\/03\/LogoEPILAB.png 1200w\" sizes=\"auto, (max-width: 300px) 100vw, 300px\" \/><\/div><\/div><\/div><div id=\"pg-35811-8\"  class=\"panel-grid panel-no-style\" ><div id=\"pgc-35811-8-0\"  class=\"panel-grid-cell\" ><div id=\"panel-35811-8-0-0\" class=\"so-panel widget widget_sow-editor panel-first-child panel-last-child\" data-index=\"11\" ><div\n\t\t\t\n\t\t\tclass=\"so-widget-sow-editor so-widget-sow-editor-base\"\n\t\t\t\n\t\t>\n<div class=\"siteorigin-widget-tinymce textwidget\">\n\t<p><strong>EVerZom<\/strong> (Erganeo) - <a href=\"https:\/\/everzom.com\/\">everzom.com<\/a><\/p>\n<p>EVerZom, est au service de la m\u00e9decine r\u00e9g\u00e9n\u00e9rative avec des outils biologiques nouveaux : les v\u00e9sicules extracellulaires ou exosomes, qui sont aujourd\u2019hui consid\u00e9r\u00e9es comme prometteurs pour la m\u00e9decine r\u00e9g\u00e9n\u00e9rative. EVerZom d\u00e9veloppe un proc\u00e9d\u00e9 de production in\u00e9dit pouvant \u00eatre d\u00e9velopp\u00e9 \u00e0 l\u2019\u00e9chelle industrielle afin de produire \u00e0 haut rendement ces v\u00e9sicules extracellulaires. Cette innovation permet de produire 10 fois plus de v\u00e9sicules extracellulaires en 10 fois moins de temps et s\u2019impl\u00e9mente directement dans des syst\u00e8mes compatibles avec les certifications cliniques pour r\u00e9pondre aux besoins m\u00e9dicaux. L\u2019ambition d\u2019EVerZom est de se positionner comme le premier fabricant europ\u00e9en de v\u00e9sicules extracellulaires \u00e0 destination des acteurs industriels d\u00e9veloppant les bioth\u00e9rapies v\u00e9siculaires de demain.<\/p>\n<\/div>\n<\/div><\/div><\/div><div id=\"pgc-35811-8-1\"  class=\"panel-grid-cell\" ><div id=\"panel-35811-8-1-0\" class=\"so-panel widget widget_media_image panel-first-child panel-last-child\" data-index=\"12\" ><img loading=\"lazy\" decoding=\"async\" width=\"300\" height=\"158\" src=\"https:\/\/www.satt.fr\/wp-content\/uploads\/2023\/03\/images-300x158.png\" class=\"image wp-image-35783  attachment-medium size-medium\" alt=\"\" style=\"max-width: 100%; height: auto;\" srcset=\"https:\/\/www.satt.fr\/wp-content\/uploads\/2023\/03\/images-300x158.png 300w, https:\/\/www.satt.fr\/wp-content\/uploads\/2023\/03\/images-1024x538.png 1024w, https:\/\/www.satt.fr\/wp-content\/uploads\/2023\/03\/images-150x79.png 150w, https:\/\/www.satt.fr\/wp-content\/uploads\/2023\/03\/images-768x403.png 768w, https:\/\/www.satt.fr\/wp-content\/uploads\/2023\/03\/images-500x263.png 500w, https:\/\/www.satt.fr\/wp-content\/uploads\/2023\/03\/images-600x315.png 600w, https:\/\/www.satt.fr\/wp-content\/uploads\/2023\/03\/images-190x100.png 190w, https:\/\/www.satt.fr\/wp-content\/uploads\/2023\/03\/images.png 1200w\" sizes=\"auto, (max-width: 300px) 100vw, 300px\" \/><\/div><\/div><\/div><div id=\"pg-35811-9\"  class=\"panel-grid panel-no-style\" ><div id=\"pgc-35811-9-0\"  class=\"panel-grid-cell\" ><div id=\"panel-35811-9-0-0\" class=\"so-panel widget widget_sow-editor panel-first-child panel-last-child\" data-index=\"13\" ><div\n\t\t\t\n\t\t\tclass=\"so-widget-sow-editor so-widget-sow-editor-base\"\n\t\t\t\n\t\t>\n<div class=\"siteorigin-widget-tinymce textwidget\">\n\t<p><strong>Healshape<\/strong> (PULSALYS) - <a href=\"https:\/\/healshape.com\/fr\/accueil\/\">healshape.com<\/a><\/p>\n<p>Healshape est une entreprise de m\u00e9decine r\u00e9g\u00e9n\u00e9rative dont la vocation est de r\u00e9parer l\u2019humain en lui donnant la possibilit\u00e9 de se r\u00e9g\u00e9n\u00e9rer gr\u00e2ce \u00e0 ses propres cellules. Sa premi\u00e8re ambition est la reconstruction mammaire. Elle a ainsi d\u00e9velopp\u00e9 une bioproth\u00e8se mammaire pour les femmes ayant subi une mastectomie suite \u00e0 un cancer du sein. Cette bioproth\u00e8se est une matrice naturelle fabriqu\u00e9e \u00e0 partir de mati\u00e8res biosourc\u00e9es, bior\u00e9sorbable et imprim\u00e9e en 3D, permettant en association \u00e0 du lipofilling de r\u00e9g\u00e9n\u00e9rer les tissus de la patiente en une op\u00e9ration chirurgicale simple pour un r\u00e9sultat esth\u00e9tique et naturel. Healshape veut permettre \u00e0 des millions de femmes dans le monde de choisir leur solution de reconstruction mammaire avec s\u00e9r\u00e9nit\u00e9.<\/p>\n<\/div>\n<\/div><\/div><\/div><div id=\"pgc-35811-9-1\"  class=\"panel-grid-cell\" ><div id=\"panel-35811-9-1-0\" class=\"so-panel widget widget_media_image panel-first-child panel-last-child\" data-index=\"14\" ><img loading=\"lazy\" decoding=\"async\" width=\"300\" height=\"158\" src=\"https:\/\/www.satt.fr\/wp-content\/uploads\/2023\/03\/291bbbf5-66b4-4a35-b9bc-e605036b8aa2-300x158.jpeg\" class=\"image wp-image-35777  attachment-medium size-medium\" alt=\"\" style=\"max-width: 100%; height: auto;\" srcset=\"https:\/\/www.satt.fr\/wp-content\/uploads\/2023\/03\/291bbbf5-66b4-4a35-b9bc-e605036b8aa2-300x158.jpeg 300w, https:\/\/www.satt.fr\/wp-content\/uploads\/2023\/03\/291bbbf5-66b4-4a35-b9bc-e605036b8aa2-1024x538.jpeg 1024w, https:\/\/www.satt.fr\/wp-content\/uploads\/2023\/03\/291bbbf5-66b4-4a35-b9bc-e605036b8aa2-150x79.jpeg 150w, https:\/\/www.satt.fr\/wp-content\/uploads\/2023\/03\/291bbbf5-66b4-4a35-b9bc-e605036b8aa2-768x403.jpeg 768w, https:\/\/www.satt.fr\/wp-content\/uploads\/2023\/03\/291bbbf5-66b4-4a35-b9bc-e605036b8aa2-500x263.jpeg 500w, https:\/\/www.satt.fr\/wp-content\/uploads\/2023\/03\/291bbbf5-66b4-4a35-b9bc-e605036b8aa2-600x315.jpeg 600w, https:\/\/www.satt.fr\/wp-content\/uploads\/2023\/03\/291bbbf5-66b4-4a35-b9bc-e605036b8aa2-190x100.jpeg 190w, https:\/\/www.satt.fr\/wp-content\/uploads\/2023\/03\/291bbbf5-66b4-4a35-b9bc-e605036b8aa2.jpeg 1200w\" sizes=\"auto, (max-width: 300px) 100vw, 300px\" \/><\/div><\/div><\/div><div id=\"pg-35811-10\"  class=\"panel-grid panel-no-style\" ><div id=\"pgc-35811-10-0\"  class=\"panel-grid-cell\" ><div id=\"panel-35811-10-0-0\" class=\"so-panel widget widget_sow-editor panel-first-child panel-last-child\" data-index=\"15\" ><div\n\t\t\t\n\t\t\tclass=\"so-widget-sow-editor so-widget-sow-editor-base\"\n\t\t\t\n\t\t>\n<div class=\"siteorigin-widget-tinymce textwidget\">\n\t<p><strong>inHEART<\/strong> (Aquitaine Science Transfert) - <a href=\"https:\/\/www.inheartmedical.com\/\">inheartmedical.com<\/a><\/p>\n<p>inHEART d\u00e9veloppe et commercialise des solutions logicielles sur le cloud de traitement d'images m\u00e9dicales pour mieux planifier et guider les interventions d'ablation par cath\u00e9ter sur les arythmies cardiaques. inHEART fournit \u00e0 partir de ces images pr\u00e9op\u00e9ratoires un jumeau num\u00e9rique du coeur du patient qui rend ces interventions plus simples, plus rapides etplus efficaces !<\/p>\n<\/div>\n<\/div><\/div><\/div><div id=\"pgc-35811-10-1\"  class=\"panel-grid-cell\" ><div id=\"panel-35811-10-1-0\" class=\"so-panel widget widget_media_image panel-first-child panel-last-child\" data-index=\"16\" ><img loading=\"lazy\" decoding=\"async\" width=\"300\" height=\"158\" src=\"https:\/\/www.satt.fr\/wp-content\/uploads\/2023\/03\/telechargement-300x158.jpg\" class=\"image wp-image-35789  attachment-medium size-medium\" alt=\"\" style=\"max-width: 100%; height: auto;\" srcset=\"https:\/\/www.satt.fr\/wp-content\/uploads\/2023\/03\/telechargement-300x158.jpg 300w, https:\/\/www.satt.fr\/wp-content\/uploads\/2023\/03\/telechargement-1024x538.jpg 1024w, https:\/\/www.satt.fr\/wp-content\/uploads\/2023\/03\/telechargement-150x79.jpg 150w, https:\/\/www.satt.fr\/wp-content\/uploads\/2023\/03\/telechargement-768x403.jpg 768w, https:\/\/www.satt.fr\/wp-content\/uploads\/2023\/03\/telechargement-500x263.jpg 500w, https:\/\/www.satt.fr\/wp-content\/uploads\/2023\/03\/telechargement-600x315.jpg 600w, https:\/\/www.satt.fr\/wp-content\/uploads\/2023\/03\/telechargement-190x100.jpg 190w, https:\/\/www.satt.fr\/wp-content\/uploads\/2023\/03\/telechargement.jpg 1200w\" sizes=\"auto, (max-width: 300px) 100vw, 300px\" \/><\/div><\/div><\/div><div id=\"pg-35811-11\"  class=\"panel-grid panel-no-style\" ><div id=\"pgc-35811-11-0\"  class=\"panel-grid-cell\" ><div id=\"panel-35811-11-0-0\" class=\"so-panel widget widget_sow-editor panel-first-child panel-last-child\" data-index=\"17\" ><div\n\t\t\t\n\t\t\tclass=\"so-widget-sow-editor so-widget-sow-editor-base\"\n\t\t\t\n\t\t>\n<div class=\"siteorigin-widget-tinymce textwidget\">\n\t<p><strong>Poietis<\/strong> (Aquitaine Science Transfert) - <a href=\"https:\/\/poietis.com\/\">poietis.com<\/a><\/p>\n<p>Poietis est une entreprise de technologie de la sant\u00e9 sp\u00e9cialis\u00e9e dans le d\u00e9veloppement et la fabrication de tissus biologiques par Bio-impression. Poietis a d\u00e9velopp\u00e9 la plateforme robotis\u00e9e et multimodale Next Generation Bioprinting (NGB) compatible avec les Bonnes Pratiques de Fabrication et la production de tissus humains bio-imprim\u00e9s implantables.<\/p>\n<\/div>\n<\/div><\/div><\/div><div id=\"pgc-35811-11-1\"  class=\"panel-grid-cell\" ><div id=\"panel-35811-11-1-0\" class=\"so-panel widget widget_media_image panel-first-child panel-last-child\" data-index=\"18\" ><img loading=\"lazy\" decoding=\"async\" width=\"300\" height=\"158\" src=\"https:\/\/www.satt.fr\/wp-content\/uploads\/2023\/03\/cropped-Logo_Poietis_Transparent-2-300x158.png\" class=\"image wp-image-35781  attachment-medium size-medium\" alt=\"\" style=\"max-width: 100%; height: auto;\" srcset=\"https:\/\/www.satt.fr\/wp-content\/uploads\/2023\/03\/cropped-Logo_Poietis_Transparent-2-300x158.png 300w, https:\/\/www.satt.fr\/wp-content\/uploads\/2023\/03\/cropped-Logo_Poietis_Transparent-2-1024x538.png 1024w, https:\/\/www.satt.fr\/wp-content\/uploads\/2023\/03\/cropped-Logo_Poietis_Transparent-2-150x79.png 150w, https:\/\/www.satt.fr\/wp-content\/uploads\/2023\/03\/cropped-Logo_Poietis_Transparent-2-768x403.png 768w, https:\/\/www.satt.fr\/wp-content\/uploads\/2023\/03\/cropped-Logo_Poietis_Transparent-2-500x263.png 500w, https:\/\/www.satt.fr\/wp-content\/uploads\/2023\/03\/cropped-Logo_Poietis_Transparent-2-600x315.png 600w, https:\/\/www.satt.fr\/wp-content\/uploads\/2023\/03\/cropped-Logo_Poietis_Transparent-2-190x100.png 190w, https:\/\/www.satt.fr\/wp-content\/uploads\/2023\/03\/cropped-Logo_Poietis_Transparent-2.png 1200w\" sizes=\"auto, (max-width: 300px) 100vw, 300px\" \/><\/div><\/div><\/div><div id=\"pg-35811-12\"  class=\"panel-grid panel-no-style\" ><div id=\"pgc-35811-12-0\"  class=\"panel-grid-cell\" ><div id=\"panel-35811-12-0-0\" class=\"so-panel widget widget_sow-editor panel-first-child panel-last-child\" data-index=\"19\" ><div\n\t\t\t\n\t\t\tclass=\"so-widget-sow-editor so-widget-sow-editor-base\"\n\t\t\t\n\t\t>\n<div class=\"siteorigin-widget-tinymce textwidget\">\n\t<p><strong>Qubit Pharmaceuticals<\/strong> (Lutech) - <a href=\"https:\/\/qubit-pharmaceuticals.com\/\">qubit-pharmaceuticals.com<\/a><\/p>\n<p>Qubit Pharmaceuticals con\u00e7oit ses candidats m\u00e9dicaments atome par atome pour optimiser leur efficacit\u00e9 et leur sp\u00e9cificit\u00e9 avec un profil de s\u00e9curit\u00e9 favorable \u00e0 une vitesse sans pr\u00e9c\u00e9dent. Gr\u00e2ce a Atlas, sa plateforme de conception de m\u00e9dicaments, Qubit Pharmaceuticals r\u00e9duit le temps et le cout de d\u00e9couverte d'un m\u00e9dicament d'un facteur 2.<\/p>\n<\/div>\n<\/div><\/div><\/div><div id=\"pgc-35811-12-1\"  class=\"panel-grid-cell\" ><div id=\"panel-35811-12-1-0\" class=\"so-panel widget widget_media_image panel-first-child panel-last-child\" data-index=\"20\" ><img loading=\"lazy\" decoding=\"async\" width=\"300\" height=\"158\" src=\"https:\/\/www.satt.fr\/wp-content\/uploads\/2023\/03\/social-300x158.jpg\" class=\"image wp-image-35787  attachment-medium size-medium\" alt=\"\" style=\"max-width: 100%; height: auto;\" srcset=\"https:\/\/www.satt.fr\/wp-content\/uploads\/2023\/03\/social-300x158.jpg 300w, https:\/\/www.satt.fr\/wp-content\/uploads\/2023\/03\/social-1024x538.jpg 1024w, https:\/\/www.satt.fr\/wp-content\/uploads\/2023\/03\/social-150x79.jpg 150w, https:\/\/www.satt.fr\/wp-content\/uploads\/2023\/03\/social-768x403.jpg 768w, https:\/\/www.satt.fr\/wp-content\/uploads\/2023\/03\/social-500x263.jpg 500w, https:\/\/www.satt.fr\/wp-content\/uploads\/2023\/03\/social-600x315.jpg 600w, https:\/\/www.satt.fr\/wp-content\/uploads\/2023\/03\/social-190x100.jpg 190w, https:\/\/www.satt.fr\/wp-content\/uploads\/2023\/03\/social.jpg 1200w\" sizes=\"auto, (max-width: 300px) 100vw, 300px\" \/><\/div><\/div><\/div><div id=\"pg-35811-13\"  class=\"panel-grid panel-no-style\" ><div id=\"pgc-35811-13-0\"  class=\"panel-grid-cell\" ><div id=\"panel-35811-13-0-0\" class=\"so-panel widget widget_sow-editor panel-first-child panel-last-child\" data-index=\"21\" ><div\n\t\t\t\n\t\t\tclass=\"so-widget-sow-editor so-widget-sow-editor-base\"\n\t\t\t\n\t\t>\n<div class=\"siteorigin-widget-tinymce textwidget\">\n\t<p><strong>StemInov<\/strong> (SAYENS) - <a href=\"https:\/\/www.steminov.com\/\">steminov.com<\/a><\/p>\n<p>StemInov est une spin-off du CHRU de Nancy et de l'universit\u00e9 de Lorraine qui d\u00e9veloppe un m\u00e9dicament de th\u00e9rapie innovante \u00e0 base de cellules souches issues du cordon ombilical pour traiter les pathologies inflammatoires avec pour premi\u00e8re indication le choc septique et le syndrome de d\u00e9tresse respiratoire aigu.<\/p>\n<\/div>\n<\/div><\/div><\/div><div id=\"pgc-35811-13-1\"  class=\"panel-grid-cell\" ><div id=\"panel-35811-13-1-0\" class=\"so-panel widget widget_media_image panel-first-child panel-last-child\" data-index=\"22\" ><img loading=\"lazy\" decoding=\"async\" width=\"300\" height=\"158\" src=\"https:\/\/www.satt.fr\/wp-content\/uploads\/2023\/03\/1599126354924-300x158.jpg\" class=\"image wp-image-35779  attachment-medium size-medium\" alt=\"\" style=\"max-width: 100%; height: auto;\" srcset=\"https:\/\/www.satt.fr\/wp-content\/uploads\/2023\/03\/1599126354924-300x158.jpg 300w, https:\/\/www.satt.fr\/wp-content\/uploads\/2023\/03\/1599126354924-1024x538.jpg 1024w, https:\/\/www.satt.fr\/wp-content\/uploads\/2023\/03\/1599126354924-150x79.jpg 150w, https:\/\/www.satt.fr\/wp-content\/uploads\/2023\/03\/1599126354924-768x403.jpg 768w, https:\/\/www.satt.fr\/wp-content\/uploads\/2023\/03\/1599126354924-500x263.jpg 500w, https:\/\/www.satt.fr\/wp-content\/uploads\/2023\/03\/1599126354924-600x315.jpg 600w, https:\/\/www.satt.fr\/wp-content\/uploads\/2023\/03\/1599126354924-190x100.jpg 190w, https:\/\/www.satt.fr\/wp-content\/uploads\/2023\/03\/1599126354924.jpg 1200w\" sizes=\"auto, (max-width: 300px) 100vw, 300px\" \/><\/div><\/div><\/div><div id=\"pg-35811-14\"  class=\"panel-grid panel-no-style\" ><div id=\"pgc-35811-14-0\"  class=\"panel-grid-cell\" ><div id=\"panel-35811-14-0-0\" class=\"so-panel widget widget_sow-editor panel-first-child panel-last-child\" data-index=\"23\" ><div\n\t\t\t\n\t\t\tclass=\"so-widget-sow-editor so-widget-sow-editor-base\"\n\t\t\t\n\t\t>\n<div class=\"siteorigin-widget-tinymce textwidget\">\n\t<h2 style=\"text-align: center;\"><strong>Accompagnement de la Mission French Tech<\/strong><\/h2>\n<\/div>\n<\/div><\/div><\/div><\/div><div id=\"pg-35811-15\"  class=\"panel-grid panel-no-style\" ><div id=\"pgc-35811-15-0\"  class=\"panel-grid-cell\" ><div id=\"panel-35811-15-0-0\" class=\"so-panel widget widget_sow-editor panel-first-child panel-last-child\" data-index=\"24\" ><div\n\t\t\t\n\t\t\tclass=\"so-widget-sow-editor so-widget-sow-editor-base\"\n\t\t\t\n\t\t>\n<div class=\"siteorigin-widget-tinymce textwidget\">\n\t<p>Les 21 start-up s\u00e9lectionn\u00e9es b\u00e9n\u00e9ficieront pendant un an de l\u2019accompagnement de la Mission French Tech, c\u2019est-\u00e0-dire l\u2019acc\u00e8s au r\u00e9seau des Correspondants French Tech dans plus de 60 services publics et d\u2019une visibilit\u00e9 renforc\u00e9e en France et \u00e0 l\u2019international.<\/p>\n<p><strong>Une visibilit\u00e9 renforc\u00e9e en France et \u00e0 l\u2019International<\/strong><\/p>\n<ul>\n<li>La visibilit\u00e9 apport\u00e9e aux entreprises aura pour objectif de valoriser les solutions de l\u2019\u00e9cosyst\u00e8me French Tech, aupr\u00e8s du tissu \u00e9conomique (PME, ETI, notamment industrielles), des acteurs publics ou \u00e0 l\u2019international, et d\u2019acc\u00e9l\u00e9rer le d\u00e9ploiement concret de leurs solutions.<\/li>\n<\/ul>\n<p><strong>Un appui de l\u2019\u00c9tat pour soutenir le d\u00e9veloppement des entreprises<\/strong><\/p>\n<ul>\n<li>Sur le mod\u00e8le de l\u2019accompagnement propos\u00e9 aux entreprises du French Tech Next40\/120, les start-up du French Tech Health20 b\u00e9n\u00e9ficieront d\u2019un accompagnement quotidien sur mesure d\u2019une dur\u00e9e de 1 an.<\/li>\n<\/ul>\n<\/div>\n<\/div><\/div><\/div><\/div><div id=\"pg-35811-16\"  class=\"panel-grid panel-no-style\" ><div id=\"pgc-35811-16-0\"  class=\"panel-grid-cell\" ><div id=\"panel-35811-16-0-0\" class=\"so-panel widget widget_sow-editor panel-first-child panel-last-child\" data-index=\"25\" ><div\n\t\t\t\n\t\t\tclass=\"so-widget-sow-editor so-widget-sow-editor-base\"\n\t\t\t\n\t\t>\n<div class=\"siteorigin-widget-tinymce textwidget\">\n\t<p><font size=\"+2\"><\/p>\n<p style=\"text-align: center;\"><a href=\"https:\/\/lafrenchtech.com\/wp-content\/uploads\/2023\/03\/Dossier-de-presse-French-Tech-Health20-2023.pdf\"><strong>&gt; Le dossier de presse &lt;<\/strong><\/a><\/p>\n<p><\/font><\/p>\n<\/div>\n<\/div><\/div><\/div><\/div><\/div>","protected":false},"excerpt":{"rendered":"<p>Le 28 mars, Jean-No\u00ebl Barrot, Ministre d\u00e9l\u00e9gu\u00e9 charg\u00e9 de la Transition num\u00e9rique et des T\u00e9l\u00e9communications, Clara Chappaz, Directrice de la Mission French Tech et Lise Alter, Directrice g\u00e9n\u00e9rale de l\u2019Agence de l\u2019innovation en sant\u00e9 (SGPI), ont d\u00e9voil\u00e9s les laur\u00e9ats du programme French Tech Health20. 21 startups ont \u00e9t\u00e9 s\u00e9lectionn\u00e9es pour participer au programme d\u2019acc\u00e9l\u00e9ration, dont [&hellip;]<\/p>\n","protected":false},"author":2,"featured_media":35806,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[567],"tags":[],"class_list":["post-35811","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-news-en"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.4 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>French Tech Health20 : 7 startups SATT au sein de la premi\u00e8re promotion ! - R\u00e9seau SATT<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.satt.fr\/en\/french-tech-health20\/\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"admin\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.satt.fr\\\/en\\\/french-tech-health20\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.satt.fr\\\/en\\\/french-tech-health20\\\/\"},\"author\":{\"name\":\"admin\",\"@id\":\"https:\\\/\\\/www.satt.fr\\\/en\\\/#\\\/schema\\\/person\\\/6f20a7d0bc03146f6e34a9f08d941fec\"},\"headline\":\"French Tech Health20 : 7 startups SATT au sein de la premi\u00e8re promotion !\",\"datePublished\":\"2023-03-29T08:44:16+00:00\",\"dateModified\":\"2023-03-29T08:45:51+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.satt.fr\\\/en\\\/french-tech-health20\\\/\"},\"wordCount\":1319,\"image\":{\"@id\":\"https:\\\/\\\/www.satt.fr\\\/en\\\/french-tech-health20\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.satt.fr\\\/wp-content\\\/uploads\\\/2023\\\/03\\\/Fr_9VopXwAYpjr5.jpg\",\"articleSection\":[\"News\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.satt.fr\\\/en\\\/french-tech-health20\\\/\",\"url\":\"https:\\\/\\\/www.satt.fr\\\/en\\\/french-tech-health20\\\/\",\"name\":\"French Tech Health20 : 7 startups SATT au sein de la premi\u00e8re promotion ! - R\u00e9seau SATT\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.satt.fr\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.satt.fr\\\/en\\\/french-tech-health20\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.satt.fr\\\/en\\\/french-tech-health20\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.satt.fr\\\/wp-content\\\/uploads\\\/2023\\\/03\\\/Fr_9VopXwAYpjr5.jpg\",\"datePublished\":\"2023-03-29T08:44:16+00:00\",\"dateModified\":\"2023-03-29T08:45:51+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.satt.fr\\\/en\\\/#\\\/schema\\\/person\\\/6f20a7d0bc03146f6e34a9f08d941fec\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.satt.fr\\\/en\\\/french-tech-health20\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.satt.fr\\\/en\\\/french-tech-health20\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.satt.fr\\\/en\\\/french-tech-health20\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.satt.fr\\\/wp-content\\\/uploads\\\/2023\\\/03\\\/Fr_9VopXwAYpjr5.jpg\",\"contentUrl\":\"https:\\\/\\\/www.satt.fr\\\/wp-content\\\/uploads\\\/2023\\\/03\\\/Fr_9VopXwAYpjr5.jpg\",\"width\":2048,\"height\":1153},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.satt.fr\\\/en\\\/french-tech-health20\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Accueil\",\"item\":\"https:\\\/\\\/www.satt.fr\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"French Tech Health20 : 7 startups SATT au sein de la premi\u00e8re promotion !\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.satt.fr\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/www.satt.fr\\\/en\\\/\",\"name\":\"R\u00e9seau SATT\",\"description\":\"Les Soci\u00e9t\u00e9s d&#039;Acc\u00e9l\u00e9ration du Transfert de Technologies\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.satt.fr\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.satt.fr\\\/en\\\/#\\\/schema\\\/person\\\/6f20a7d0bc03146f6e34a9f08d941fec\",\"name\":\"admin\",\"url\":\"https:\\\/\\\/www.satt.fr\\\/en\\\/author\\\/admin\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"French Tech Health20 : 7 startups SATT au sein de la premi\u00e8re promotion ! - R\u00e9seau SATT","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.satt.fr\/en\/french-tech-health20\/","twitter_misc":{"Written by":"admin"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.satt.fr\/en\/french-tech-health20\/#article","isPartOf":{"@id":"https:\/\/www.satt.fr\/en\/french-tech-health20\/"},"author":{"name":"admin","@id":"https:\/\/www.satt.fr\/en\/#\/schema\/person\/6f20a7d0bc03146f6e34a9f08d941fec"},"headline":"French Tech Health20 : 7 startups SATT au sein de la premi\u00e8re promotion !","datePublished":"2023-03-29T08:44:16+00:00","dateModified":"2023-03-29T08:45:51+00:00","mainEntityOfPage":{"@id":"https:\/\/www.satt.fr\/en\/french-tech-health20\/"},"wordCount":1319,"image":{"@id":"https:\/\/www.satt.fr\/en\/french-tech-health20\/#primaryimage"},"thumbnailUrl":"https:\/\/www.satt.fr\/wp-content\/uploads\/2023\/03\/Fr_9VopXwAYpjr5.jpg","articleSection":["News"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.satt.fr\/en\/french-tech-health20\/","url":"https:\/\/www.satt.fr\/en\/french-tech-health20\/","name":"French Tech Health20 : 7 startups SATT au sein de la premi\u00e8re promotion ! - R\u00e9seau SATT","isPartOf":{"@id":"https:\/\/www.satt.fr\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.satt.fr\/en\/french-tech-health20\/#primaryimage"},"image":{"@id":"https:\/\/www.satt.fr\/en\/french-tech-health20\/#primaryimage"},"thumbnailUrl":"https:\/\/www.satt.fr\/wp-content\/uploads\/2023\/03\/Fr_9VopXwAYpjr5.jpg","datePublished":"2023-03-29T08:44:16+00:00","dateModified":"2023-03-29T08:45:51+00:00","author":{"@id":"https:\/\/www.satt.fr\/en\/#\/schema\/person\/6f20a7d0bc03146f6e34a9f08d941fec"},"breadcrumb":{"@id":"https:\/\/www.satt.fr\/en\/french-tech-health20\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.satt.fr\/en\/french-tech-health20\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.satt.fr\/en\/french-tech-health20\/#primaryimage","url":"https:\/\/www.satt.fr\/wp-content\/uploads\/2023\/03\/Fr_9VopXwAYpjr5.jpg","contentUrl":"https:\/\/www.satt.fr\/wp-content\/uploads\/2023\/03\/Fr_9VopXwAYpjr5.jpg","width":2048,"height":1153},{"@type":"BreadcrumbList","@id":"https:\/\/www.satt.fr\/en\/french-tech-health20\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Accueil","item":"https:\/\/www.satt.fr\/en\/"},{"@type":"ListItem","position":2,"name":"French Tech Health20 : 7 startups SATT au sein de la premi\u00e8re promotion !"}]},{"@type":"WebSite","@id":"https:\/\/www.satt.fr\/en\/#website","url":"https:\/\/www.satt.fr\/en\/","name":"R\u00e9seau SATT","description":"Les Soci\u00e9t\u00e9s d&#039;Acc\u00e9l\u00e9ration du Transfert de Technologies","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.satt.fr\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.satt.fr\/en\/#\/schema\/person\/6f20a7d0bc03146f6e34a9f08d941fec","name":"admin","url":"https:\/\/www.satt.fr\/en\/author\/admin\/"}]}},"_links":{"self":[{"href":"https:\/\/www.satt.fr\/en\/wp-json\/wp\/v2\/posts\/35811","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.satt.fr\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.satt.fr\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.satt.fr\/en\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.satt.fr\/en\/wp-json\/wp\/v2\/comments?post=35811"}],"version-history":[{"count":4,"href":"https:\/\/www.satt.fr\/en\/wp-json\/wp\/v2\/posts\/35811\/revisions"}],"predecessor-version":[{"id":35817,"href":"https:\/\/www.satt.fr\/en\/wp-json\/wp\/v2\/posts\/35811\/revisions\/35817"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.satt.fr\/en\/wp-json\/wp\/v2\/media\/35806"}],"wp:attachment":[{"href":"https:\/\/www.satt.fr\/en\/wp-json\/wp\/v2\/media?parent=35811"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.satt.fr\/en\/wp-json\/wp\/v2\/categories?post=35811"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.satt.fr\/en\/wp-json\/wp\/v2\/tags?post=35811"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}